Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06821594
EARLY_PHASE1

Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts at Tertiary Care Hospital in Karachi.

Sponsor: Jinnah Postgraduate Medical Centre

View on ClinicalTrials.gov

Summary

Identify the effects of combined intralesional furosemide 20mg/2ml and digoxin 0.5mg/2ml in cutaneous warts given weekly are rather safe and effective treatment for cutaneous warts, focusing on their effectiveness and safety, at a tertiary care hospital in Karachi, Pakistan.

Official title: Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts.

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2025-04-01

Completion Date

2025-09-30

Last Updated

2025-02-12

Healthy Volunteers

No

Conditions

Interventions

DRUG

Furosemide

Furosemide 20mg/2ml and digoxin 0.5mg/2ml given 0.2 ml into the wart base once weekly for 5 weeks

Locations (1)

Jinnah Postgraduate Medical Centre

Karachi, Sindh, Pakistan